Earnings Call · Q4 FY2023·2024-02-29

Q4 23EPS +14.29%·Rev n/aQ3 23EPS 0.00%·Rev n/aQ2 23EPS +16.67%·Rev n/aQ1 23EPS +16.67%·Rev n/a⚠ consensus missing

GoodRx Holdings, Inc. GDRX

Whitney Notaro — Vice President of Investor Relations

Scott Wagner — Interim Chief Executive Officer

Karsten Voermann — Chief Financial Officer

+13.3%1d on move date+12.7% vs SPY3d+16.3%5d+10.9%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more GDRX calls or request research access.

More GDRX calls Browse calls Request research access